Current psychiatric and ethical issues in solid organ transplantation

被引:0
|
作者
Surman, OS [1 ]
Kawai, T [1 ]
Cosimi, AB [1 ]
机构
[1] Wang Ambulatory Care Ctr, Dept Psychiat, Boston, MA 02114 USA
来源
NEW DIRECTIONS FOR CELLULAR AND ORGAN TRANSPLANTATION | 2000年 / 1210卷
关键词
body image; cyclosporine toxicity; cytomegalovirus; medical compliance; organ donor; patient selection;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
All countries lack insufficient organs to meet medical needs. Laws are necessary for distribution of these scarce resources. Transplantation policies and procedures vary internationally. Differences occur in the selection of transplant recipients, and in the utilization of cadaveric or living organ donor tissue. Three ethical models for transplant candidate selection are an individual rights model, a utilitarian model and a medical model. Generally the medical model prevails. It requires that treatment be available to those who can benefit. A patient's capacity to benefit from solid organ transplantation depends on medical and psychosocial factors. Psychosocial factors affect adherence to essential medical routines and follow-up care. Education, belief and life style also have a great impact on patient compliance. Transplantation programs must therefore provide effective teaching and perioperative support. Primary and secondary prevention of psychopathological states is also essential. This paper reviews current ethical and psychological factors in organ procurement, candidate selection, and perioperative care of the organ transplant recipient.
引用
收藏
页码:227 / 234
页数:8
相关论文
共 50 条
  • [31] Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis
    Zhang, Yu
    Zhou, Tao
    Huang, Mingzhu
    Gu, Guangxiang
    Xia, Qiang
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2020, 19 (01)
  • [32] Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantation
    Pangonis, Scott
    Paulsen, Grant
    Andersen, Heidi
    Flores, Francisco
    Miethke, Alexander
    Peters, Anna
    Kocoshis, Samuel
    Lazear, Danielle
    Garr, BreAnn
    Schecter, Marc
    Chin, Clifford
    Hemmelgarn, Trina
    Danziger-Isakov, Lara
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (02)
  • [33] Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis
    Yu Zhang
    Tao Zhou
    Mingzhu Huang
    Guangxiang Gu
    Qiang Xia
    Annals of Clinical Microbiology and Antimicrobials, 19
  • [34] International Survey of Cytomegalovirus Management in Solid Organ Transplantation After the Publication of Consensus Guidelines
    Le Page, Amelia K.
    Jager, Mischa M.
    Kotton, Camille N.
    Simoons-Smit, Alberdina
    Rawlinson, William D.
    TRANSPLANTATION, 2013, 95 (12) : 1455 - 1460
  • [36] Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation:: A collaborative transplant study report
    Opelz, G
    Döhler, B
    Ruhenstroth, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) : 928 - 936
  • [37] Uniform Definitions for Donor-Derived Infectious Disease Transmissions in Solid Organ Transplantation
    Garzoni, Christian
    Ison, Michael G.
    TRANSPLANTATION, 2011, 92 (12) : 1297 - 1300
  • [38] Psychiatric assessment in transplantation
    Messias, E
    Skotzko, CE
    REVISTA DE SAUDE PUBLICA, 2000, 34 (04): : 415 - 420
  • [39] Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation
    Fernandez-Ruiz, Mario
    Kumar, Deepali
    Humar, Atul
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2014, 3
  • [40] Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
    Razonable, Raymund R.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 3987 - 4001